PATENT CLAIM ANALYSIS

Application Number: 16363626
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "001000"]

Abstract:
Methods of treating cancer using and kits comprising at least one gemcitabine, at least one nab-paclitaxel, and at least one compound of formula (I)

Claim (Index 46):
The method according to  claim 41 , wherein the pancreatic cancer is metastatic pancreatic ductal adenocarcinoma.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 99.0
- Lexical Diversity: 1.47368
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15981406', '12677513', '15114465', '12677516', '16246829']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7393740354622078
- 35 USC 102 Novelty (BERT): 0.5296864282720063
- Combined Prediction Score: 0.7184052747431876
- Mean Citation Score: 237.133348
- Max Citation Score: 311.71622
- Similarity Product: 208.24062452624324

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test